Skip to main content

Table 2 Sensitivity and specificity of the routine malaria information system (RMIS) in detecting stock-outs observed during four end-user verification (EUV) surveys, Guinea

From: Evaluating the quality of routinely reported data on malaria commodity stocks in Guinea, 2014–2016

Commodity

EUV Jul 2014

EUV Dec 2014

EUV Oct 2015

EUV Aug 2016

Total

Sensitivitya

Specificityb

Sensitivitya

Specificityb

Sensitivitya

Specificityb

Sensitivitya

Specificityb

Sensitivitya

Specificityb

RDT

4/4 (100%)

20/21 (95%)

1/3 (33%)

17/17 (100%)

4/5 (80%)

16/24 (67%)

7/15 (47%)

24/27 (89%)

16/27 (59%)

77/89 (87%)

ASAQ infant

2/4 (50%)

19/21 (90%)

0/1 (0%)

19/20 (95%)

0/2 (0%)

21/21 (100%)

12/16 (75%)

21/26 (81%)

14/23 (61%)

80/88 (91%)

ASAQ small child

1/2 (50%)

20/23 (87%)

20/20 (100%)

21/23 (91%)

9/17 (53%)

23/26 (88%)

10/19 (53%)

84/92 (91%)

ASAQ child

1/2 (50%)

21/23 (91%)

0/2 (0%)

17/19 (89%)

22/23 (96%)

4/10 (40%)

28/30 (93%)

5/14 (36%)

88/95 (93%)

ASAQ adult

1/3 (33%)

17/22 (77%)

2/4 (50%)

15/17 (88%)

1/1 (100%)

20/23 (87%)

5/5 (100%)

32/34 (94%)

9/13 (69%)

84/96 (88%)

AL

5/5 (100%)

13/14 (93%)

8/8 (100%)

13/14 (93%)

13/13 (100%)

SP

2/4 (50%)

19/20 (95%)

0/2 (0%)

15/16 (94%)

2/3 (67%)

24/24 (100%)

1/7 (14%)

30/34 (88%)

5/16 (31%)

88/94 (94%)

Injectable artesunate

15/15 (100%)

0/1 (0%)

15/15 (100%)

5/5 (100%)

1/3 (33%)

2/3 (67%)

10/12 (83%)

0/1 (0%)

41/45 (91%)

7/10 (70%)

Injectable artemether

5/5 (100%)

19/20 (95%)

0/1 (0%)

1/1 (100%)

2/6 (33%)

26/26 (100%)

4/7 (57%)

51/52 (98%)

6/14 (43%)

Injectable quinine

1/1 (100%)

23/24 (96%)

3/5 (60%)

14/16 (88%)

6/9 (67%)

12/17 (71%)

15/21 (71%)

13/17 (76%)

25/36 (69%)

62/74 (84%)

Quinine tablet

13/15 (87%)

5/9 (56%)

14/16 (88%)

3/4 (75%)

9/10 (90%)

10/16 (62%)

3/15 (20%)

23/27 (85%)

39/56 (70%)

41/56 (73%)

LLIN

8/8 (100%)

8/8 (100%)

5/9 (56%)

5/8 (62%)

1/1 (100%)

18/20 (90%)

14/18 (78%)

16/18 (89%)

28/36 (78%)

47/54 (87%)

All commodities

53/63 (84%)

152/172 (88%)

59/77 (77%)

130/143 (91%)

25/35 (71%)

173/205 (84%)

119/176 (68%)

222/255 (87%)

256/351 (73%)

677/775 (87%)

  1. RDT Rapid diagnostic test, ASAQ artesunate–amodiaquine, AL artemether–lumefantrine, SP sulfadoxine–pyrimethamine, LLIN long-lasting insecticidal net
  2. a Proportion of health facilities without stock during the EUV survey that had also reported a stock-out in their RMIS report
  3. b Proportion of health facilities that were not stocked-out during the EUV survey that had not reported a stock-out in their RMIS report